Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   
Gene: TFDP3 (transcription factor Dp family member 3) Homo sapiens
Symbol: TFDP3
Name: transcription factor Dp family member 3
Description: This gene encodes a member of the DP family of transcription factors. These factors heterodimerize with E2F proteins to enhance their DNA-binding activity and promote transcription from E2F target genes. This protein functions as a negative regulator and inhibits the DNA binding and transcriptional activities of E2F factors.[provided by RefSeq, May 2010]
Type: protein-coding
RefSeq Status: REVIEWED
Also known as: cancer/testis antigen 30; CT30; DP4; E2F-like; HCA661; hepatocellular carcinoma-associated antigen 661; MGC161639; transcription factor Dp family, member 3
Pan paniscus (bonobo/pygmy chimpanzee) : TFDP3 (transcription factor Dp family member 3)
more info ...
Allele / Splice: See ClinVar data
Latest Assembly: GRCh38 - Human Genome Assembly GRCh38
Human AssemblyChrPosition (strand)SourceGenome Browsers
GRCh38X133,216,669 - 133,218,348 (-)NCBIGRCh38GRCh38hg38GRCh38
GRCh37X132,350,697 - 132,352,376 (-)NCBIGRCh37GRCh37hg19GRCh37
Build 36X132,178,363 - 132,180,042 (-)NCBINCBI36hg18NCBI36
Build 34X132,076,216 - 132,077,896NCBI
CeleraX132,737,132 - 132,738,811 (-)NCBI
Cytogenetic MapXq26.2NCBI
HuRefX121,754,908 - 121,756,587 (-)NCBIHuRef
CHM1_1X132,262,216 - 132,263,895 (-)NCBICHM1_1
JBrowse: View Region in Genome Browser (JBrowse)

Disease Annotations
Gene-Chemical Interaction Annotations
Gene Ontology Annotations
References - curated
References - uncurated


Comparative Map Data
Position Markers
miRNA Target Status


Nucleotide Sequences
Protein Sequences
Clinical Variants

Additional Information

External Database Links
Nomenclature History
More on TFDP3
Alliance Gene
Ensembl Gene
JBrowse: hg19 hg38
HGNC Report
NCBI Genome Data Viewer

CRRD Object Information
CRRD ID: 1353749
Created: 2005-03-08
Species: Homo sapiens
Last Modified: 2019-06-18
Status: ACTIVE


RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.